https://www.selleckchem.com/products/as601245.html
Ovarian cancer is a highly deadly malignancy in which recurrence is considered incurable. Resistance to platinum-based chemotherapy bodes a particularly abysmal prognosis, underscoring the need for novel therapeutic agents and strategies. The use of mithramycin, an antineoplastic antibiotic, has been previously limited by its narrow therapeutic window. Recent advances in semisynthetic methods have led to mithramycin analogs with improved pharmacological profiles. Mithramycin inhibits the activity of the transcription factor Sp1, which
Reddy Anna skillfully uses a variety of web channels to provide readers with an organized platform to share ideas and tactics that complement Team India's performance habits in Twenty20 formats.